Kishore Kamal, Mahajan Rahul
Department of Biostatistics, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Department of Dermatology, Venereology, and Leprology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Indian Dermatol Online J. 2020 Sep 19;11(6):890-894. doi: 10.4103/idoj.IDOJ_130_20. eCollection 2020 Nov-Dec.
Randomized control trialsare the gold standard for testing the efficacy of new interventions. Historically, superiority trials were methods of choice as reference (standard) interventions were not established for many disease conditions. However currently, reference interventions are available for most of adverse conditions. Despite this, many investigators are using superiority trials in comparison to more suitable noninferiority and equivalence trials. The application of noninferiority and equivalence trials is on the rise, but by and large, these trials are poorly understood, ill-conceived, inappropriately analyzed, and reported and misinterpreted.
随机对照试验是测试新干预措施疗效的金标准。从历史上看,优效性试验是首选方法,因为许多疾病状况尚未确立参考(标准)干预措施。然而,目前大多数不良状况都有了参考干预措施。尽管如此,与更合适的非劣效性试验和等效性试验相比,许多研究者仍在使用优效性试验。非劣效性试验和等效性试验的应用正在增加,但总体而言,这些试验仍未得到充分理解、构思不当、分析和报告有误且被误解。